STEMCELL LTD

Company Registration Number:
15069541 (England and Wales)

Unaudited statutory accounts for the year ended 31 December 2025

Period of accounts

Start date: 1 January 2025

End date: 31 December 2025

STEMCELL LTD

Contents of the Financial Statements

for the Period Ended 31 December 2025

Profit and loss
Balance sheet
Additional notes

STEMCELL LTD

Profit And Loss Account

for the Period Ended 31 December 2025

2025 17 months to 31 December 2024


£
£
Turnover: 33,170 6,485
Cost of sales: ( 4,051 ) ( 5,230 )
Gross profit(or loss): 29,119 1,255
Distribution costs: 0
Administrative expenses: ( 34 ) ( 74 )
Other operating income: 0
Operating profit(or loss): 29,085 1,181
Interest receivable and similar income: 0
Interest payable and similar charges: 0
Profit(or loss) before tax: 29,085 1,181
Tax: ( 5,526 ) ( 224 )
Profit(or loss) for the financial year: 23,559 957

STEMCELL LTD

Balance sheet

As at 31 December 2025

Notes 2025 17 months to 31 December 2024


£
£
Called up share capital not paid: 1 1
Current assets
Cash at bank and in hand: 1,016 1,181
Total current assets: 1,016 1,181
Net current assets (liabilities): 1,016 1,181
Total assets less current liabilities: 1,017 1,182
Total net assets (liabilities): 1,017 1,182
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 1,016 1,181
Total Shareholders' funds: 1,017 1,182

The notes form part of these financial statements

STEMCELL LTD

Balance sheet statements

For the year ending 31 December 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 31 March 2026
and signed on behalf of the board by:

Name: Robert Butterworth
Status: Director

The notes form part of these financial statements

STEMCELL LTD

Notes to the Financial Statements

for the Period Ended 31 December 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

STEMCELL LTD

Notes to the Financial Statements

for the Period Ended 31 December 2025

  • 2. Employees

    2025 17 months to 31 December 2024
    Average number of employees during the period 1 1